Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Colitis, Ulcerative × Adalimumab × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 4 Psoriasis 2 Crohn Disease 2 Uveal Melanoma 1 Spondylitis, Ankylosing 1 Plaque Psoriasis 1 Melanoma 1 Healthy Adult Male 1 Healthy 1 Colitis, Ulcerative 1

Interventions

etrolizumab 4 Infliximab 3 peficitinib 1 golimumab 1 NX-13 1 Methylprednisolone 1 Mesalamine 1 Injections 1 CT-P13 1 Andrographis paniculata extract 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02163759 2021-07-23

HIBISCUS I

Hoffmann-La Roche

Phase 3 Completed

358 enrolled 42 charts

Colitis, Ulcerative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡